Progress in the treatment of diabetic macular edema with faricimab: a review. [PDF]
Gao M, Liu C, Zeng Y, Wu X, Duan J.
europepmc +1 more source
"Real world outcomes of intravitreal brolucizumab for persistent diabetic macular edema". [PDF]
Hansraj S +4 more
europepmc +1 more source
Aqueous Humor Biomarkers, Efficacy, and Safety in Patients with Naïve Diabetic Macular Edema Treated with Faricimab: The ALTIMETER Study. [PDF]
Schlottmann PG +16 more
europepmc +1 more source
Pharmacological Treatment for Diabetic Macular Edema: A 2025 Update on Durability and Multi-Target Therapies. [PDF]
Tao Y, Zhang Y, Xu W, Liu G, Liu H.
europepmc +1 more source
Serial Aqueous Humor Proteomics in Diabetic Macular Edema: Correlation of Novel Targets with Retinal Fluid Volume. [PDF]
Cehofski LJ +8 more
europepmc +1 more source
A comparative study on the efficacy and safety of biosimilar (Rimmyrah) and reference ranibizumab in patients with diabetic macular edema. [PDF]
Zhai G, Ren X, Xu B, Mi D.
europepmc +1 more source
Multimodal imaging biomarkers associated with recurrence of diabetic macular edema during aflibercept treat-and-extend therapy. [PDF]
Kim K, Lee J, Choi J, Yu SY.
europepmc +1 more source
Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN). [PDF]
Barkmeier AJ +15 more
europepmc +1 more source
Long-Term Intravitreal Dexamethasone Implant Monotherapy in Naïve Patients with Diabetic Macular Edema. [PDF]
Karataş G +7 more
europepmc +1 more source

